Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Terbutaline (1.25mg/5ml) + Acebrophylline (50mg/5ml) + Guaifenesin (50mg/5ml) Syrup
Therapeutic Category
Cold and Cough, General and OTC medicines, Pulmonary, Respiratory, Asthma
Dosage Form
Syrup
Packaging Type
with Carton and Measuring Cap
Packaging
100 ml
Price
₹139/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Abrostep Plus Syrup is an effective combination of Terbutaline (1.25mg/5ml), Acebrophylline (50mg/5ml), and Guaifenesin (50mg/5ml), specifically formulated to address respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and productive cough. This syrup works through a synergistic mechanism to provide relief from bronchospasms, ease mucus expulsion, and improve overall respiratory function.
This triple-action formula not only eases breathing difficulties but also promotes faster recovery from respiratory distress by addressing airway inflammation and mucus build-up. Its formulation makes it suitable for patients experiencing conditions like asthma, bronchitis, or other obstructive airway diseases.
Common side effects include nausea, headache, mild tremors, or an upset stomach. Consult a healthcare provider if side effects persist or worsen.
Indicated for the management of asthma, COPD, and productive cough by improving airway function and facilitating mucus clearance.
Use under medical supervision, especially for individuals who are pregnant, breastfeeding, or on other medications. Avoid exceeding the prescribed dose.
Store in a cool, dry place below 30°C. Protect from direct sunlight and keep out of reach of children.
Composition : Bilastine (20mg) + Montelukast (10mg) Tablet
Composition : Doxofylline (400mg)
Composition : Doxofylline (400mg) + Ambroxol (30mg)
Composition : Doxofylline (400mg) + Montelukast (10mg)
Composition : Ebastine (10mg) + Montelukast (10mg)
Composition : Montelukast (10mg) + Fexofenadine (120mg)
Composition : Levocetirizine (2.5mg) + Montelukast (4mg) Bilayered
Composition : Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Composition : Desloratadine (5mg) + Montelukast (10mg)
Composition : Montelukast (10mg) + Fexofenadine (120mg) + Acebrophylline (200mg) (Sustained Release)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Acebrophylline + Terbutaline + Guaifenesin Syrup is a comprehensive respiratory formulation used for the management of productive cough, bronchitis, asthma, COPD, chest congestion, and other respiratory tract disorders associated with mucus accumulation. Acebrophylline acts as a bronchodilator and mucoregulator, helping improve airflow and reduce mucus viscosity. Terbutaline is a bronchodilator that relaxes airway muscles and eases breathing. Guaifenesin is an expectorant that helps loosen and expel mucus from the respiratory tract. This combination makes it a strong product in the respiratory and pulmonology segment.
Medical distributors and wholesalers can benefit from high prescription demand from pulmonologists, pediatricians, and general physicians, especially during seasonal respiratory infections and pollution-related respiratory illnesses. Respiratory syrups are among the most frequently prescribed products, ensuring steady sales and repeat orders.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in respiratory, pulmonology, and cough-care segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high seasonal demand, increasing respiratory disease prevalence, and strong physician prescribing patterns, making it a fast-moving, high-volume, and stable pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in respiratory and cough-care formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the respiratory and pulmonology segment.